AtriCure
ATRC
191 hedge funds and large institutions have $2.92B invested in AtriCure in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 75 reducing their positions, and 38 closing their positions.
980% more call options, than puts
Call options by funds: $5.03M | Put options by funds: $466K
19% more capital invested
Capital invested by funds: $2.45B → $2.92B (+$470M)
0.1% more ownership
Funds ownership: 97.75% → 97.85% (+0.1%)
4% less funds holding
Funds holding: 198 → 191 (-7)
13% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 38
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
31% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$147M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.9M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$39.3M |
| 4 |
FAM
Fred Alger Management
New York
|
+$20.5M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$68.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$43.5M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$24.9M |
| 4 |
Goldman Sachs
New York
|
-$22.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$12.3M |
ATRC Hedge Fund Activity: Q1 2021 in Review
191 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2021, worth a combined $2.92B — up 19% from $2.45B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of ATRC and 33 opened new positions — a net loss of 5 holders — while 75 trimmed existing stakes and 52 added.
The largest buyer was AllianceBernstein, adding an estimated $147M. The largest seller was OrbiMed, exiting entirely with an estimated $68.4M sold.
- 191 institutional investors held AtriCure (ATRC) as of Q1 2021, down from 198 in Q4 2020.
- Funds reported $2.92B of AtriCure stock for Q1 2021, up 19% quarter-over-quarter.
- 33 funds opened new AtriCure positions in Q1 2021 and 38 closed out, a net change of -5 holders.
- The largest AtriCure buyer in Q1 2021 was AllianceBernstein, an estimated $147M added.
- The largest AtriCure seller in Q1 2021 was OrbiMed, an estimated $68.4M sold.
Based on aggregated 13F filings for Q1 2021.